Published in Br J Pharmacol on March 01, 1988
Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A (1991) 2.64
Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium. Br J Pharmacol (1989) 1.13
Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am J Physiol Heart Circ Physiol (2009) 1.01
The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside. Br J Pharmacol (1988) 0.95
Pharmacological evaluation of a guinea-pig tracheal epithelium-derived inhibitory factor (EpDIF). Br J Pharmacol (1990) 0.94
Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol (1988) 0.94
Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br J Pharmacol (1988) 0.92
Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway. J Cardiovasc Pharmacol (2013) 0.88
Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta. Br J Pharmacol (1999) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther (1985) 9.91
The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol (1984) 6.74
The nature of endothelium-derived vascular relaxant factor. Nature (1984) 5.53
Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest (1986) 3.59
The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol (1985) 3.29
A new approach to anti-inflammatory drugs. Biochem Pharmacol (1979) 2.95
Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol (1985) 2.24
Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res (1986) 2.14
Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1986) 2.03
2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim Biophys Acta (1982) 1.53
Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol (1987) 1.53
The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem Pharmacol (1980) 1.45
1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins (1978) 1.39
The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur J Pharmacol (1984) 1.37
Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem (1981) 1.28
Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. J Pharmacol Exp Ther (1983) 1.28
The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed function oxidation reactions. Biochem Soc Symp (1972) 1.27
Species-dependent differences in the nature of endothelium-derived vascular relaxing factor. Eur J Pharmacol (1984) 1.17
6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies. Prostaglandins (1982) 1.12
Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun (1983) 1.10
Selective inhibition by gossypol of endothelium-dependent relaxations augments relaxations to glyceryl trinitrate in rabbit coeliac artery. Br J Pharmacol (1987) 1.09
Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension (1986) 1.09
Characterization of vascular relaxant factor released from cultured endothelial cells. Hypertension (1987) 1.05
Endothelium-dependent vasodilation by melittin: are lipoxygenase products involved? Am J Physiol (1985) 1.02
Cytochrome P-450-dependent monooxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J Pharmacol Exp Ther (1986) 1.01
Effects of cytochrome P-450 inhibitors on endothelium-dependent relaxation in rabbit aorta. Blood Vessels (1984) 0.95
Alpha-naphthoflavone: an inhibitor of hydrocarbon cytotoxicity and microsomal hydroxylase. Science (1969) 0.94
Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenases. Biochim Biophys Acta (1985) 0.93
Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther (1982) 0.93
In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol (1983) 0.81
Modulation of guanylate cyclase by lipoxygenase inhibitors. Hypertension (1986) 0.80
Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. Xenobiotica (1984) 0.79
Arachidonate 5-lipoxygenase and its new inhibitors. J Allergy Clin Immunol (1984) 0.77
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett (1990) 2.84
Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett (1990) 2.57
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20
Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg (1998) 2.16
Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res (1986) 2.14
Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun (1989) 2.02
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem (1999) 1.78
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol (1988) 1.69
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol (1987) 1.53
Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) (1983) 1.47
Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension (2000) 1.43
L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol (1998) 1.39
Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. Clin Sci (Lond) (1987) 1.39
[Aspirin--yes, but 30 mg??]. Z Kardiol (1995) 1.39
Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg (1995) 1.36
Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res (1987) 1.35
Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol (1993) 1.34
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol (1999) 1.32
S-nitrosation of serum albumin by dinitrosyl-iron complex. J Biol Chem (1995) 1.30
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett (2000) 1.29
Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc Pharmacol (1989) 1.29
Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25
Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest (1984) 1.24
Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+. Biochem J (1990) 1.24
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun (1999) 1.22
Nitric oxide and inflammatory joint diseases. Br J Rheumatol (1998) 1.22
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. J Biol Chem (1980) 1.21
Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension (2000) 1.21
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20
Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. Adv Prostaglandin Thromboxane Res (1978) 1.19
Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun (1996) 1.19
Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res (1998) 1.18
The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett (1988) 1.15
L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Lond) (1994) 1.14
The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med (2001) 1.14
Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications. Biochem J (1994) 1.14
Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol (1998) 1.14
Subcellular localization and characterization of neuronal nitric oxide synthase. J Neurochem (1994) 1.11
Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther (1986) 1.10
Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb (1991) 1.08
Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells. J Pharmacol Exp Ther (1991) 1.06
Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05
Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol (1991) 1.05
L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation (1996) 1.05
Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem Biophys Res Commun (2005) 1.04
The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03
Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol (1978) 1.03
Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth. Eur J Clin Pharmacol (1993) 1.03
The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med (1978) 1.02
The stereochemical course of the reaction catalyzed by soluble bovine lung guanylate cyclase. J Biol Chem (1983) 1.02
Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis (1995) 1.01
Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler (1992) 1.01
Indomethacin increases plasma lithium. Br Med J (1979) 1.01
Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest (1997) 1.01
Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol (1994) 1.00
cAMP attenuates autacoid release from endothelial cells: relation to internal calcium. Am J Physiol (1990) 0.99
Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther (1975) 0.99
Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest (1993) 0.98
Rhythmic smooth muscle activity in hamster aortas is mediated by continuous release of NO from the endothelium. Am J Physiol (1991) 0.98
Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol (1990) 0.97
Effects of cimetidine and ranitidine on steady-state propranolol kinetics and dynamics. Clin Pharmacol Ther (1982) 0.97
Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.97
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol (1998) 0.96
Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state. Eur J Clin Pharmacol (1983) 0.96
Regional differences in prostacyclin formation by the kidney. Prostacyclin is a major prostaglandin of renal cortex. Biochim Biophys Acta (1978) 0.95
Effects of diclofenac on lithium kinetics. Clin Pharmacol Ther (1981) 0.95
Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int (1996) 0.94
Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. J Cardiovasc Pharmacol (1986) 0.94
Endothelium-dependent relaxation of human epicardial coronary arteries: frequent lack of effect of acetylcholine. Eur J Pharmacol (1986) 0.94
In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation (1996) 0.93
Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat. Br J Pharmacol (1987) 0.93
On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem (1991) 0.92
Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol (1990) 0.92
Epr evidence of nitric oxide production by the regenerating rat liver. Biochem Biophys Res Commun (1994) 0.92
Importance of NO/EDRF for glomerular and tubular function: studies in the isolated perfused rat kidney. Kidney Int (1992) 0.92
Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res (1988) 0.91
Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs. J Chromatogr B Biomed Appl (1994) 0.91
Indomethacin but not aspirin increases plasma lithium ion levels. Arch Gen Psychiatry (1983) 0.91
Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay--solutions by gas chromatography-mass spectrometry. Anal Biochem (1997) 0.91
Investigations of S-transnitrosylation reactions between low- and high-molecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal Biochem (1999) 0.91
The participation of prostaglandins in the control of renin release. Fed Proc (1979) 0.91
[Incidence and prevention of lethal undesirable drug effects]. Internist (Berl) (2003) 0.91
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention. Circ Res (1979) 0.90
Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (1998) 0.90
L-arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide. Immunology (1990) 0.90
Ca(++)-dependent constitutive nitric oxide synthase is not involved in the cyclic GMP-increasing effects of carbachol in ventricular cardiomyocytes. J Pharmacol Exp Ther (1993) 0.90
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol (2002) 0.90
Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk (1994) 0.89
Effect of aprotinin on the renal response to vasopressin in diabetes insipidus rats. J Physiol (1983) 0.89
Measurement of prostaglandins, thromboxanes, prostacyclin and their metabolites by gas liquid chromatography--mass spectrometry. Adv Prostaglandin Thromboxane Res (1978) 0.89